JP2021523379A5 - - Google Patents
Info
- Publication number
- JP2021523379A5 JP2021523379A5 JP2020564247A JP2020564247A JP2021523379A5 JP 2021523379 A5 JP2021523379 A5 JP 2021523379A5 JP 2020564247 A JP2020564247 A JP 2020564247A JP 2020564247 A JP2020564247 A JP 2020564247A JP 2021523379 A5 JP2021523379 A5 JP 2021523379A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- inhibit
- biomarkers
- treatment
- sample
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1807789.1 | 2018-05-14 | ||
| GBGB1807789.1A GB201807789D0 (en) | 2018-05-14 | 2018-05-14 | Serum biomarkers |
| GBGB1816764.3A GB201816764D0 (en) | 2018-10-15 | 2018-10-15 | Serum biomarkers |
| GB1816764.3 | 2018-10-15 | ||
| GBGB1817024.1A GB201817024D0 (en) | 2018-10-19 | 2018-10-19 | Serum biomarkers |
| GB1817024.1 | 2018-10-19 | ||
| PCT/EP2019/062215 WO2019219612A1 (en) | 2018-05-14 | 2019-05-13 | Serum biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523379A JP2021523379A (ja) | 2021-09-02 |
| JP2021523379A5 true JP2021523379A5 (https=) | 2022-05-20 |
| JPWO2019219612A5 JPWO2019219612A5 (https=) | 2022-05-20 |
Family
ID=66589527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564247A Pending JP2021523379A (ja) | 2018-05-14 | 2019-05-13 | 血清バイオマーカー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210215697A1 (https=) |
| EP (1) | EP3794352A1 (https=) |
| JP (1) | JP2021523379A (https=) |
| CN (1) | CN112639474A (https=) |
| WO (1) | WO2019219612A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202004189D0 (en) * | 2020-03-23 | 2020-05-06 | Bergenbio As | Combination therapy |
| AU2021409465A1 (en) | 2020-12-21 | 2023-08-03 | Freenome Holdings, Inc. | Markers for the early detection of colon cell proliferative disorders |
| WO2023059527A1 (en) * | 2021-10-04 | 2023-04-13 | Tintoria Piana, Inc. | Diagnostic system and methods of using and manufacturing the same |
| CN118359697A (zh) * | 2024-04-29 | 2024-07-19 | 上海硅羿生物技术有限公司 | β淀粉样蛋白40及β淀粉样蛋白42特异识别多肽及其应用 |
| CN121186348B (zh) * | 2025-11-25 | 2026-02-24 | 北京大学人民医院 | 瓜氨酸化内凝集素-1多肽在制备类风湿关节炎诊断产品中的应用 |
| CN121186360B (zh) * | 2025-11-25 | 2026-04-14 | 长兴固容生物科技有限公司 | 一种用于乳腺癌筛查、诊断的标志物组及其用途 |
| CN121186365B (zh) * | 2025-11-25 | 2026-04-14 | 长兴固容生物科技有限公司 | 一种用于胰腺癌筛查、诊断的标志物组及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| WO2006125143A2 (en) * | 2005-05-18 | 2006-11-23 | Novartis Ag | Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| WO2014055543A2 (en) * | 2012-10-01 | 2014-04-10 | Millennium Pharmaceuticals, Inc. | Biomarkers and methods to predict response to inhibitors and uses thereof |
| GB201410826D0 (en) * | 2014-06-18 | 2014-07-30 | Bergenbio As | Anti-axl antibodies |
| GB201410825D0 (en) * | 2014-06-18 | 2014-07-30 | Bergenbio As | Anti-axl antibodies |
| JP6931609B2 (ja) * | 2014-12-18 | 2021-09-08 | ベルゲン テクノロジオーヴァーフォリング エイエス | 抗Ａｘｌアンタゴニスト抗体 |
| CA2971763A1 (en) | 2014-12-23 | 2016-06-30 | Bergenbio Asa | Inhibitors of akt kinase |
| GB201506411D0 (en) * | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201512133D0 (en) * | 2015-07-10 | 2015-08-19 | Bergenbio As | Biomarkers |
-
2019
- 2019-05-13 JP JP2020564247A patent/JP2021523379A/ja active Pending
- 2019-05-13 US US17/054,193 patent/US20210215697A1/en not_active Abandoned
- 2019-05-13 EP EP19724776.0A patent/EP3794352A1/en not_active Withdrawn
- 2019-05-13 CN CN201980045744.6A patent/CN112639474A/zh active Pending
- 2019-05-13 WO PCT/EP2019/062215 patent/WO2019219612A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523379A5 (https=) | ||
| JP6630766B2 (ja) | 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法 | |
| JP6786499B2 (ja) | 膵癌のバイオマーカー | |
| KR102185987B1 (ko) | Ripk3을 포함하는 당뇨병성 신증 진단용 바이오마커 및 이의 용도 | |
| KR102442803B1 (ko) | 결장직장암에 대한 복합 테스트 | |
| CN105705652B (zh) | 协助鉴别诊断中风的方法 | |
| Xu et al. | Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma | |
| US20090298097A1 (en) | Methods for the diagnosis of lung cancer | |
| CN106662543A (zh) | 肺癌患者中的非侵入性基因突变检测 | |
| JP2018529931A5 (https=) | ||
| JP2022553420A (ja) | 敗血症管理 | |
| Choi et al. | Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients—A retrospective clinical assessment | |
| JPWO2019219612A5 (https=) | ||
| CA3218787A1 (en) | Protein biomarkers for non-alcoholic fatty liver disease (nafld) | |
| Lee et al. | Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease | |
| KR102018205B1 (ko) | 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법 | |
| US20250197944A1 (en) | Differential diagnosis method | |
| WO2011148669A1 (ja) | 大腸がんマーカービトロネクチン、及び採血試料中のビトロネクチン濃度の分析方法 | |
| KR20200049647A (ko) | 반려동물에서 종양질병의 보조적 진단을 위한 바이오마커 검사방법 | |
| KR101334123B1 (ko) | 소세포폐암 진단용 조성물 및 소세포폐암 진단키트 | |
| KR102453551B1 (ko) | 급성 췌장염 중증도 진단용 정보 제공 방법 | |
| JP6145650B2 (ja) | 卵巣癌マーカー及び卵巣癌検出方法 | |
| KR20220129816A (ko) | 미만형 위암의 예후 진단 마커 | |
| CN113981092A (zh) | 用于预测肿瘤药物敏感性的生物标志物及其相关产品 | |
| JPWO2022043930A5 (https=) |